Literature DB >> 6456062

Lymphoid subpopulations of peripheral blood and spleen in untreated Hodgkin's disease.

M R Posner, E L Reinherz, J Breard, L M Nadler, D S Rosenthal, S F Schlossman.   

Abstract

A panel of monoclonal antibodies with well-defined specificities were used as probes to investigate the phenotypes and lineage of circulating lymphoid cells and splenocytes in untreated patients with Hodgkin's disease. A significant relative and absolute reduction in T cells (anti-T3+) was found only in patients with B-symptoms. There was no alteration in the fraction of helper (anti-T4+) or cytotoxic/suppressor (anti-T5+) T cells circulating in peripheral blood when compared to normals, nor was there activation of these cells as measured by the development of surface Ia (anti-I1+). Circulating T cell subsets were not altered 5 to 14 days after splenectomy. Splenic T cells were increased equally in involved and uninvolved spleen when compared with control spleens obtained from accident victims. These findings indicate that abnormal T cell function in Hodgkin's disease may be the result of subtle alterations in T cells or non-T immunoregulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6456062     DOI: 10.1002/1097-0142(19810901)48:5<1170::aid-cncr2820480522>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  The role of the spleen in leukemias and lymphomas including Hodgkin's disease.

Authors:  R Maurer
Journal:  Experientia       Date:  1985-02-15

2.  Reed-Sternberg/lymphocyte rosette: lymphocyte subpopulations as defined by monoclonal antibodies.

Authors:  C S Morris; A E Stuart
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

3.  Morphological and immunohistochemical studies of Hodgkin's disease in the spleen.

Authors:  M Takeshita; S Falk; J Schwetje; H J Stutte
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

4.  Effect of sera from patients with Hodgkin's disease on normal donor lymphocytes containing parallel tubular structures.

Authors:  J W Smit; N R Blom; M J van Luyn; G W van Imhoff; M R Halie
Journal:  Blut       Date:  1984-02

5.  The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients.

Authors:  R S Doggett; G S Wood; S Horning; R Levy; R F Dorfman; J Bindl; R A Warnke
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

6.  Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease.

Authors:  R N Damle; R J Tatake; S H Advani; S G Gangal
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

Review 7.  Cancer Immunotherapy and the Immune Response in Hodgkin Lymphoma.

Authors:  Christoph Renner; Frank Stenner
Journal:  Front Oncol       Date:  2018-06-04       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.